Dienogest alone or dienogest combined with estrogens in the treatment of ovarian endometriomas, that is the question. A retrospective cohort study
Open Access
- 12 July 2023
- journal article
- research article
- Published by Springer Nature in Archives of Gynecology and Obstetrics
- Vol. 308 (4) , 1341-1349
Abstract
Purpose: to compare the effects of Dienogest 2 mg (D) alone or combined with estrogens (D + ethinylestradiol 0.03 mg, D + EE; D + estradiol valerate 1–3 mg, D + EV) in terms of symptoms and endometriotic lesions variations.Methods: This retrospective study included symptomatic patients in reproductive age with ultrasound diagnosis of ovarian endometriomas. Medical therapy for at least 12 months with D, D + EE or D + EV was required. Women were evaluated at baseline visit (V1) and after 6 (V2) and 12 months (V3) of therapy.Results: 297 patients were enrolled (156 in the D group, 58 in the D + EE group, 83 in the D + EV group). Medical treatment leaded to a significant reduction in size of endometriomas after 12 months, with no differences between the three groups. When comparing D and D + EE/D + EV groups, a significant decrease of dysmenorrhea was detected in the D group than in D + EE/D + EV group. Conversely, the reduction of dysuria was more significative in the D + EE/D + EV groups rather than in the D group. Regarding tolerability, treatment associated side effects were reported by 16.2% patients. The most frequent one was uterine bleeding/spotting, significantly higher in the D + EV group.Conclusion: Dienogest alone or associated with estrogens (EE/EV) seems to be equally effective in reducing endometriotic lesions mean diameter. The reduction of dysmenorrhea was more significative when D was administered alone, while dysuria seems to improve more when D is associated with estrogens.Keywords
All Related Versions
Funding Information
- Alma Mater Studiorum - Università di Bologna
This publication has 33 references indexed in Scilit:
- Comparison between the stripping technique and the combined excisional/ablative technique for the treatment of bilateral ovarian endometriomas: a multicentre RCTHuman Reproduction, 2015
- Safety and tolerability of dienogest in endometriosis: pooled analysis from the European clinical study programInternational Journal of Women's Health, 2015
- Terms, definitions and measurements to describe sonographic features of myometrium and uterine masses: a consensus opinion from the Morphological Uterus Sonographic Assessment (MUSA) groupUltrasound in Obstetrics & Gynecology, 2015
- Modification of body composition and metabolism during oral contraceptives containing non-androgenic progestins in association with estradiol or ethinyl estradiolGynecological Endocrinology, 2014
- Norethisterone acetate versus norethisterone acetate combined with letrozole for the treatment of ovarian endometriotic cysts: a patient preference studyEuropean Journal of Obstetrics & Gynecology and Reproductive Biology, 2014
- Dienogest in long-term treatment of endometriosisInternational Journal of Women's Health, 2011
- DienogestDrugs, 2010
- Endometriomas: their ultrasound characteristicsUltrasound in Obstetrics & Gynecology, 2010
- Recurrence of endometriosis and its controlHuman Reproduction Update, 2009
- Relations entre endométriose et algie pelvienne chronique : quel est le niveau de preuve ?Gynécologie Obstétrique & Fertilité, 2009